Refractory Anemia With Excess of Blasts (RAEB)
Also known as: Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts / RAEB / Refractory anemia with an excess of blasts / MDS-refractory anemia with excess blasts (RAEB) / Anemia, Refractory, With Excess of Blasts / Refractory anaemia with an excess of blasts / Refractory Anemia With Excess Blasts / Myelodysplastic syndrome with excess blasts / Refractory anemia with excess of blasts [RAEB] / Refractory anemia with excess of blasts, unspecified / Myelodysplastic syndrome with excess blasts (disorder) / Myelodysplastic syndrome with increased blasts (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|---|---|
DB00928 | Azacitidine | A pyrimidine nucleoside analogue used to treat certain subtypes of myelodysplastic syndrome. |
DB15694 | Cedazuridine | A cytidine deaminase inhibitor coadministered with the hypomethylating agent decitabine for the treatment of variable forms of myelodysplastic syndrome (MDS). |
DB01262 | Decitabine | A chemotherapeutic pyrimidine nucleoside analogue used for the treatment of myelodysplastic syndromes (MDS) by inducing DNA hypomethylation and corresponding alterations in gene expression. |